Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy
Authors
Keywords
-
Journal
PROTEOMICS
Volume 15, Issue 2-3, Pages 365-373
Publisher
Wiley
Online
2014-10-14
DOI
10.1002/pmic.201400214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer
- (2015) Dmytro M. Havaleshko et al. NEOPLASIA
- A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
- (2014) Kimberly C Wiegand et al. BMC CANCER
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- PARP inhibitors in ovarian cancer: Current status and future promise
- (2014) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study
- (2014) Agata I. Rembielak et al. Translational Oncology
- Glioblastoma Cell Enrichment Is Critical for Analysis of Phosphorylated Drug Targets and Proteomic-Genomic Correlations
- (2013) C. Mueller et al. CANCER RESEARCH
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer
- (2013) Maurie Markman GYNECOLOGIC ONCOLOGY
- Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: A SEER analysis
- (2013) J. Alejandro Rauh-Hain et al. GYNECOLOGIC ONCOLOGY
- Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications
- (2013) Ramez N. Eskander et al. GYNECOLOGIC ONCOLOGY
- Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study
- (2013) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance
- (2013) Elaine Xu et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
- (2012) J. D. Wulfkuhle et al. CLINICAL CANCER RESEARCH
- Clear cell carcinoma of the ovary: A review of the literature
- (2012) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis
- (2012) Shuangwei Li et al. Frontiers of Medicine
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
- (2011) Michael P. Stany et al. PLoS One
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
- (2010) Alessandra Silvestri et al. LABORATORY INVESTIGATION
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability
- (2009) Virginia Espina et al. Proteomics Clinical Applications
- Body size and risk of epithelial ovarian and related cancers: A population-based case-control study
- (2008) Catherine M. Olsen et al. INTERNATIONAL JOURNAL OF CANCER
- Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy
- (2008) Julia D. Wulfkuhle et al. JOURNAL OF PROTEOME RESEARCH
- A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process
- (2008) Virginia Espina et al. MOLECULAR & CELLULAR PROTEOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started